Mark E. Bunnage

Active 1994–2025

Affiliations
Pfizer (United Kingdom)This corpus build does not record the country of an author's affiliations, so none is shown here. It does not mean these institutions have no country.
Also published as
Mark E Bunnage
21
Papers
3,878
Citations
18
h-index
21
i10-index

Self-citations are included in these numbers.

Citations per year

Citations

Citations per year for Mark E. Bunnage1999: 2 citations2000: 4 citations2001: 2 citations2002: 3 citations2003: 5 citations2004: 4 citations2005: 4 citations2006: 1 citations2007: 1 citations2008: 1 citations2009: 1 citations2010: 1 citations2011: 6 citations2012: 12 citations2013: 40 citations2014: 52 citations2015: 93 citations2016: 122 citations2017: 107 citations2018: 88 citations2019: 189 citations2020: 181 citations2021: 161 citations2022: 102 citations2023: 109 citations2024: 168 citations2025: 80 citations2026: 3 citations

Citation sources

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Fields

  • Biochemistry, Genetics and Molecular Biology52.5%
  • Medicine15.8%
  • Computer Science15.3%
  • Chemistry6.7%
  • Pharmacology, Toxicology and Pharmaceutics4.2%
  • Neuroscience1.4%
  • Other4.1%

Topics

  • Protein Degradation and Inhibitors20.5%
  • Computational Drug Discovery Methods15.9%
  • Ubiquitin and proteasome pathways7.9%
  • Click Chemistry and Applications7.1%
  • Multiple Myeloma Research and Treatments7.1%
  • Histone Deacetylase Inhibitors Research7.1%
  • Other34.5%

Frequent coauthors

All papers

Loading papers…

Mark E. Bunnage | Litlas